Trial Summary
What is the purpose of this trial?This trial tests how well the advanced care planning around mobility needs checklist tool works to assess future mobility needs in patients with sarcoma. Gathering information about sarcoma patients that have had surgery to either save or remove a limb may help doctors learn more about a patient's mobility needs. Using an advance care planning mobility needs assessment may help improve the quality of life in patients with sarcoma by helping them plan for their future mobility needs.
Eligibility Criteria
This trial is for English-speaking adults over 18 with sarcoma who've had limb surgery or are in active treatment for stage IV sarcoma. They must be able to consent and have computer access. Caregivers meeting the same criteria can also participate.Treatment Details
The study evaluates a checklist tool designed to assess future mobility needs of sarcoma patients post-surgery or during stage IV treatment, aiming to improve their quality of life by aiding in planning for mobility challenges.
1Treatment groups
Experimental Treatment
Group I: Supportive Care (advanced care planning checklist)Experimental Treatment4 Interventions
FIELD TEST: Participants complete the Advance Care Planning (ACP) Mobility Checklist on study. Participants complete questionnaires at baseline and after completing the checklist intervention and undergo interview on study. Participants medical records are also reviewed.
Assessment is already approved in United States, European Union for the following indications:
🇺🇸 Approved in United States as Temodar for:
- Glioblastoma multiforme
- Refractory anaplastic astrocytoma
🇪🇺 Approved in European Union as Temodal for:
- Glioblastoma multiforme
- Refractory anaplastic astrocytoma
Find a clinic near you
Research locations nearbySelect from list below to view details:
Fred Hutch/University of Washington Cancer ConsortiumSeattle, WA
Loading ...
Who is running the clinical trial?
Fred Hutchinson Cancer CenterLead Sponsor